Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morgane Cheminant

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2024
Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP TrialVincent Camus, Catherine Thieblemont, Philippe Gaulard, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 9, 2022
Genetic Diagnosis Guides Treatment of Autoimmune EnteropathyFabienne Charbit-Henrion, Manon Haas, Stanislas Chaussade, et al.
Journal of Clinical Immunology|November 28, 2025
IgA and IgM-enriched Immunoglobulins in Primary Immunodeficiencies: a Pilot StudyAurore Collet, Benjamin Coiffard, Emmanuel Ledoult, et al.
Hemasphere|January 22, 2025
Efficacy of anti-PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSAAmira Marouf, Sammara Chaubard, Raphaël Liévin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 19, 2024
Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineagesJean-Sélim Driouich, Maxime Cochin, Guillaume Lingas, et al.
American Journal of Hematology|July 7, 2025
Whole Exome Sequencing of Adult Patients With Evans Syndrome Reveals Pathogenic Variants Associated With AutoimmunityEtienne Crickx, Jehane Fadlallah, Morgane Cheminant, et al.
Blood|March 31, 2026
Lenalidomide plus rituximab for previously untreated advanced follicular lymphoma: the 10-year RELEVANCE trial analysisNicolas Gower, Pierre Feugier, Jason R Westin, et al.
Blood Advances|April 14, 2026
Interim assessment by circulating tumor DNA in primary mediastinal large B-cell lymphoma: a multicenter LYSA studyVincent Camus, Daphné Krzisch, Alessio Bruscaggin, et al.
The Journal of Experimental Medicine|December 14, 2022
Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiencyRomain Lévy, Florian Gothe, Mana Momenilandi, et al.
The Journal of Allergy and Clinical Immunology|June 30, 2023
Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunityMaria Elena Maccari, Martin Wolkewitz, Charlotte Schwab, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2024
Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP TrialVincent Camus, Catherine Thieblemont, Philippe Gaulard, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 9, 2022
Genetic Diagnosis Guides Treatment of Autoimmune EnteropathyFabienne Charbit-Henrion, Manon Haas, Stanislas Chaussade, et al.
Journal of Clinical Immunology|November 28, 2025
IgA and IgM-enriched Immunoglobulins in Primary Immunodeficiencies: a Pilot StudyAurore Collet, Benjamin Coiffard, Emmanuel Ledoult, et al.
Hemasphere|January 22, 2025
Efficacy of anti-PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSAAmira Marouf, Sammara Chaubard, Raphaël Liévin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 19, 2024
Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineagesJean-Sélim Driouich, Maxime Cochin, Guillaume Lingas, et al.
American Journal of Hematology|July 7, 2025
Whole Exome Sequencing of Adult Patients With Evans Syndrome Reveals Pathogenic Variants Associated With AutoimmunityEtienne Crickx, Jehane Fadlallah, Morgane Cheminant, et al.
Blood|March 31, 2026
Lenalidomide plus rituximab for previously untreated advanced follicular lymphoma: the 10-year RELEVANCE trial analysisNicolas Gower, Pierre Feugier, Jason R Westin, et al.
Blood Advances|April 14, 2026
Interim assessment by circulating tumor DNA in primary mediastinal large B-cell lymphoma: a multicenter LYSA studyVincent Camus, Daphné Krzisch, Alessio Bruscaggin, et al.
The Journal of Experimental Medicine|December 14, 2022
Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiencyRomain Lévy, Florian Gothe, Mana Momenilandi, et al.
The Journal of Allergy and Clinical Immunology|June 30, 2023
Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunityMaria Elena Maccari, Martin Wolkewitz, Charlotte Schwab, et al.
Pageof 8